Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00286_DB00932_nanopub.RA8UPwDJw_R17KdIN2QexPB8IvtY6HctLCZ6-LUO43C7s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00286_DB00932 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00286_DB00932 label "DDI between Conjugated Estrogens and Tipranavir - Conjugated estrogens may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Conjugated estrogens. Monitor for estrogen deficiency during concomitant therapy. [drugbank_resource:DB00286_DB00932]" assertion.
- drugbank_resource:DB00286_DB00932 identifier "drugbank_resource:DB00286_DB00932" assertion.
- drugbank_resource:DB00286_DB00932 title "DDI between Conjugated Estrogens and Tipranavir - Conjugated estrogens may increase the adverse dermatological effects (i.e. skin rash) of Tipranavir. Tipranavir may decrease the serum concentration Conjugated estrogens. Monitor for estrogen deficiency during concomitant therapy." assertion.
- drugbank:DB00932 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00286_DB00932 assertion.
- drugbank:DB00286 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00286_DB00932 assertion.